Your search for apixaban returned 102 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Your search for apixaban returned 102 results

Sort Results:

Relevant Recent
News

Apixaban Dosing Examined in Patients With Only One-Dose Reduction Criterion

For patients in the Apixaban for Reduction of Stroke and Other Thromboembolic Complications in Atrial Fibrillation (ARISTOTLE) trial, the 5 mg twice daily dose of apixaban is beneficial and appropriate for those with one dose-reduction criterion, according to a study published online in JAMA Cardiology.
News

Can Education Boost Adherence to Apixaban? New Data Presented

Research presented at the European Society of Cardiology Congress 2015 reports that an education program did not improve adherence to apixaban among patients with atrial fibrillation (AF) compared to usual information about the disease and treatment.
News

Prophylaxis With Apixaban Feasible for Cancer Patients

Primary venous thromboembolism prophylaxis with apixaban, an oral direct Factor Xa inhibitor, in ambulatory cancer patients undergoing first- or second-line chemotherapy for advanced or metastatic cancer, is safe and well tolerated.
News

Apixaban Beats Aspirin for Stroke Prevention in A-Fib

Apixaban is more effective than aspirin in reducing the risk of repeat stroke and systemic embolism in patients with atrial fibrillation (AF) who are unsuitable for vitamin K antagonists (VKA) therapy.